USE OF C-SRC INHIBITORS ALONE OR IN COMBINATION WITH STI571 FOR THE TREATMENT OF LEUKAEMIA

Details for Australian Patent Application No. 2002333386 (hide)

Owner NOVARTIS AG

Inventors FABBRO, Doriano; MANLEY, Paul, William; MESTAN, Jurgen; WARMUTH, Markus; HALLEK, Michael; TALPAZ, Moshe; WU, Ji; DONATO, Nicholas, J.

Pub. Number AU-A-2002333386

PCT Number PCT/EP02/08941

PCT Pub. Number WO2003/013540

Priority 60/311,690 10.08.01 US

Filing date 9 August 2002

Wipo publication date 24 February 2003

International Classifications

A61K 031/506 - not condensed and containing further heterocyclic rings

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61P 035/02 Antineoplastic agents

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/311,690 10.08.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-A-2002333386

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002333387-A closure cap

2002333385-Method and nucleic acids for the analysis of colon cancer